Page last updated: 2024-10-30

beta-lapachone and Invasiveness, Neoplasm

beta-lapachone has been researched along with Invasiveness, Neoplasm in 2 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, Z1
Zhang, L1
Zhou, J1
Zhou, S1
Li, L1
Guo, X1
Feng, G1
Ma, Z1
Huang, W1
Huang, F1
Kim, SO1
Kwon, JI1
Jeong, YK1
Kim, GY1
Kim, ND1
Choi, YH1

Other Studies

2 other studies available for beta-lapachone and Invasiveness, Neoplasm

ArticleYear
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
    Oncotarget, 2017, Jan-24, Volume: 8, Issue:4

    Topics: Animals; Antineoplastic Agents; Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome; Brain Neoplasms;

2017
Induction of Egr-1 is associated with anti-metastatic and anti-invasive ability of beta-lapachone in human hepatocarcinoma cells.
    Bioscience, biotechnology, and biochemistry, 2007, Volume: 71, Issue:9

    Topics: Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Early Growth Response Protein

2007